AI assistant
METLIFE INC — Director's Dealing 2017
Mar 2, 2017
29995_dirs_2017-03-02_5bd7edb9-4cec-411c-a6c7-7345f73dc664.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2017-02-28
Reporting Person: Townsend Christopher G (President, Asia)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-28 | Common Stock | A | 6660 | $52.44 | Acquired | 6660 | Direct |
| 2017-02-28 | Common Stock | D | 6660 | $52.44 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-28 | Employee Stock Option (Right to Buy) | $52.44 | A | 25744 | Acquired | 2027-02-27 | Common Stock (25744) | Direct |
| 2017-02-28 | Restricted Units (Cash-Payable) | $ | A | 8582 | Acquired | Common Stock (8582) | Direct |
Footnotes
F1: Cash payout of 2014-2016 Performance Units, following determination of the performance factor for such award. Each Performance Unit is settled in cash equal to the closing price of one share of MetLife, Inc. common stock on the payout date.
F2: The options become exercisable in three equal installments on February 28, 2018, 2019, and 2020.
F3: Each Restricted Unit is the contingent right to receive cash equal to the closing price of one share of MetLife, Inc. common stock on the vesting date.
F4: The Restricted Units vest in three equal installments on the first business day in March 2018, 2019 and 2020.